Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
Newsletters
Training
White Papers
Advertising
Contact Us
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> Lupin Expects Six to 10 New FDA Approvals by March
FDAnews Drug Daily Bulletin
July 29, 2010
| Vol. 7 No. 147
Lupin Expects Six to 10 New FDA Approvals by March
Pharma major Lupin expects to add six to 10 new FDA approvals by the end of fiscal 2011 to its present pipeline of 45 approvals, its managing director said on Wednesday.
The Economic Times
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Sanofi Pitched $71 Offer to Genzyme
Mylan Completes $550 Million Acquisition of Bioniche Pharma
Lonza Signs Production Deal With Glaxo
Onyx Pharma Gets Japanese Drug Development Deal